Smiths Group (LON:SMIN) Smiths Medical division today launched an updated version of its PharmGuard interoperability software for its Medfusion 4000 wireless syringe pumps.
The new version features bi-directional integration with any IHE compatible electronic medical record system, the company said. Smart pump programming allows a clinician order to be sent directly to the Medfusion pump, so nurses can validate the programmed information with less manual entry.
The PharmGuard interoperability software was released in 2015 and facilitates wireless communication of infusion data directly into patient records, which saves time in the clinician’s daily workflow, boosts accurate book-keeping, and improves patient safety by reducing manual data entry errors.
The software can also forward infusion pump alarms to hospital alarm management system to alert clinicians, Smiths Medical said.
The St. Paul, Minn-based company’s Medfusion Pump 4000 was approved in September 2011.
This week, Smiths Group said that it divested its Wallace in-vitro fertilization product line to Cooper Cos. (NYSE:COO) CooperSurgical subsidiary for $174 million (UK £140 million).
The divestiture is part of an ongoing program at Smiths to focus its portfolio on “market leading positions of scale in its chosen markets,” the company said. The company said that proceeds from the sale will be reinvested in “attractive growth opportunities.”
The Wallace division reported revenues of $24.9 million (UK £20 million) for its year ended July 31, 2016, with $14.9 million (UK £12 million) in operating profit.
